| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | FMK | GDSC1000 | pan-cancer | AAC | 0.0011 | 1 |
| mRNA | BRD-K19103580 | CTRPv2 | pan-cancer | AAC | -0.001 | 1 |
| mRNA | Docetaxel | gCSI | pan-cancer | AAC | 0.0015 | 1 |
| mRNA | NVP-BEZ235 | CTRPv2 | pan-cancer | AAC | -0.0011 | 1 |
| mRNA | BRD-K61166597 | CTRPv2 | pan-cancer | AAC | 0.00086 | 1 |
| mRNA | BRD-K45681478 | CTRPv2 | pan-cancer | AAC | 0.00095 | 1 |
| mRNA | carboplatin:etoposide (40:17 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.00069 | 1 |
| mRNA | BMS-754807 | GDSC1000 | pan-cancer | AAC | -0.00076 | 1 |
| mRNA | Sunitinib | CTRPv2 | pan-cancer | AAC | -0.00078 | 1 |
| mRNA | Irinotecan | FIMM | pan-cancer | AAC | -0.0028 | 1 |